Form 4: Surgery Partners Director Acquires Shares in Recent Transaction

Director Teresa DeLuca acquired 6,170 shares of Surgery Partners, Inc. common stock on June 6, 2024, at a price of $25.93 per share.

Summary

• On June 6, 2024, Teresa DeLuca, a director of Surgery Partners, Inc. (SGRY), acquired 6,170 shares of common stock.
• The shares were purchased at a price of $25.93 per share.
• Following the transaction, DeLuca directly owns 58,330 shares of Surgery Partners, Inc.
• The acquired shares will vest on June 6, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a director is generally viewed as a positive sign, indicating confidence in the company's prospects, but it's a routine transaction.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The document does not contain specific forward-looking statements, but the director's stock purchase could be interpreted as a positive signal regarding the company's future.

Industry Context

Insider transactions are closely monitored in the healthcare industry, as they can provide insights into management's perspective on the company's valuation and future performance. This transaction is a routine disclosure of a director's stock purchase.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, as mandated by the SEC.
• Similar filings are common across publicly traded healthcare companies, such as HCA Healthcare and Tenet Healthcare, when their directors or officers engage in stock transactions.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal.
• The transaction itself has minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates